Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.
Shares of KKR & Co. Inc. slid 8.53% to $149.30 Tuesday, on what proved to be an all-around positive trading session for the ...
The firm said it would increase its investment in the companies by $1.1 billion in total as part of its unusual strategy of ...
KKR & Co.’s business of arranging financing for its portfolio companies and other firms reported record annual fees last year ...
Last week, larger rival Blackstone also beat quarterly profit expectations, driven by a pickup in dealmaking. KKR's assets ...
Private equity giant KKR (KKR) has upped its offer price for Japan-based IT company Fuji Soft in its ongoing complex takeover ...
TOKYO (Reuters) - U.S. private equity fund KKR will raise its tender offer price for Fuji Soft shares to 9,850 yen per share ...
The U.S. investment company bought a more than one-third stake in Fuji Soft in November and has said it is best positioned to ...
U.S. private equity firm KKR will raise its offer price for Japanese IT company Fuji Soft by more than 4% to take it above a ...
KKR & Co. and Gaw Capital Partners are in talks to sell the Hyatt Regency hotel in Tokyo to Japan Hotel REIT Investment Corp.
Barclays analyst Benjamin Budish lowered the firm’s price target on KKR (KKR) to $181 from $185 and keeps an Overweight rating on the shares ...
KKR-backed healthcare data company Cotiviti is close to securing a deal to buy smaller rival Edifecs for just over $3bn, after it opted against accepting a higher bid from UnitedHealth Group out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results